Assertio Holdings

ASSERTIO HOLDINGS INC

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Penny,Stock,Investments,Taking,Off,Concept

Long Ideas

News

Penny Stocks

Insider Trades

Markets

Trading Ideas

ASRT

KRON

NANX

Assertio Holdings And 2 Other Penny Stocks Insiders Are Buying

Coins,Money,Increase,To,Profit,For,Concept,Investment,Fund,Finance

Pre-Market Outlook

BBAI

PODC

STIM

Neuronetics And 3 Other Stocks Under $3 Insiders Are Buying

Small Cap

Intraday Update

Movers

ACAD

AEVA

ASAN

BCAN

BLDE

The Beachbody Company, Inc. Class A Common Stock

BODI

BWMN

CLRO

CRBU

CTMX

DTSS

ENPH

ESGL

FNCH

GERN

GOEV

HRTG

IONM

JANX

JFBR

KITT

LEXX

LGCL

LICY

MNSO

NRXP

NUKK

OCUL

ONON

ORCL

PACK

PRST

RERE

RGLS

RNLX

SGLY

SMXT

SPPL

TALK

VINC

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Assertio Holdings Inc

Press Releases

Buxton Helmsley Calls for Senate Hearing on Well-Documented Evident Clinical Data Fraud at Assertio

Management

Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer

Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO

Health Care

Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study

Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Legal

INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Assertio Holdings, Inc. (NASDAQ: ASRT); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel

Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025

Earnings

Assertio Reports Fourth Quarter and Full Year 2024 Financial Results

Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025

BEAM

ALT5 Sigma

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals

Alto Neuroscience

AN2 Therapeutics

Biote

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical

Context Therapeutics

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Ikena Oncology

Iterum Therapeutics

Milestone Pharmaceuticals Inc. - Common Shares

Milestone Pharmaceuticals

Nutriband

OptiNose

Oramed Pharmaceuticals Inc. - Common Stock

Oramed Pharmaceuticals

Pliant Therapeutics

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals

Cassava Sciences

Scilex Holding

SCYNEXIS

Telomir Pharmaceuticals, Inc. - Common Stock

Telomir Pharmaceuticals

Universe Pharmaceuticals Inc - Ordinary Shares

Universe Pharmaceuticals

Veru

Verrica Pharmaceuticals Inc. - Common Stock

Verrica Pharmaceuticals

Ventyx Biosciences

HC Wainwright & Co.

Maxim Group

Alliance Global Partners

Lake Street

BWS Financial

Comments

Assertio Holdings

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga